History
  • No items yet
midpage
908 F.3d 872
3rd Cir.
2018

CITY OF CAMBRIDGE RETIREMENT SYSTEM, On bеhalf of itself and all others similarly situated, et al. v. ALTISOURCE ASSET MANAGEMENT CORP; WILLIAM C. ERBEY; KENNETH NAJOUR; ASHISH PANDEY; ROBIN LOWE

No. 17-2471

United States Court of Appeals, Third Circuit

PRECEDENTIAL

UNITED STATES COURT OF APPEALS

FOR THE THIRD CIRCUIT

______

No. 17-2471

______

CITY OF CAMBRIDGE RETIREMENT SYSTEM, On

behalf of

itself and all others similarly situated, et al.

v.

ALTISOURCE ASSET MANAGEMENT CORP; WILLIAM

C. ERBEY;

KENNETH NAJOUR; ASHISH PANDEY; ROBIN LOWE,

Denver Employee Retirement Plan,

Appellant

______

On Appeal from the District Court

of the Virgin Islands

(D.C. No. 1-15-cv-00004)

District Judge: Honorable Harvey Bartle, III

______

Argued May 24, 2018

Before: KRAUSE, ROTH and FISHER, Circuit Judges.

(Filed: November 14, 2018)

Steve W. Berman, Esq.

Hagens Berman Sobol Shapiro

1301 2nd Avenue, Suite 2000

Seattle, WA 98101

Vincent A. Colianni, II, Esq.

Colianni & Colianni

1138 King Street

Christiansted, VI 00820

Kevin K. Green, Esq. [ARGUED ]

Hagens Berman Sobol Shapiro

533 F Street, Suite 207

San Diego, CA 92101

Counsel for Appellant

Walter C. Carlson, Esq. [ARGUED]

Sidley Austin

One South Dearborn Street

Chicago, IL 60603

Chad C. Messier, Esq.

Dudley Topper & Feuerzeig

1000 Frederiksberg Gade

P.O. Box 756

St. Thomas, VI 00804

David S. Petron, Esq.

Sidley Austin

1501 K Street, N.W.

Washington, DC 20005

Counsel for Appellee Altisource Asset Management

Corp

John L. Hardiman, Esq.

Julia A. Malkina, Esq.

Sullivan & Cromwell

125 Broad Street

New York, NY 10004

Counsel for Appellee William C. Erbey

______

OPINION OF THE COURT

______

FISHER, Circuit Judge.

Commenting on the economic calamity that was the

South Sea Bubble—in which he lost a considerable fortune—

Sir Isaac Newton is said to have remarked, “I can calculate the

motions of the heavenly bodies, but not the madness of the

people.”1 Throughout its history, the trade of public securities

has proven to be both a powerful engine of economic growth

and an occasionally harsh reminder that what goes up must

come down.

In this securities fraud class action, former shareholders

allege that Altisource Asset Management Corporation and

several of its officers (collectively AAMC) inflated the price

of its stock through false and misleading statements. When

these mistruths were revealed to the market, the allegation

goes, the price of AAMC’s stock plummeted, costing

shareholders billions оf dollars. The District Court dismissed

the complaint for failure to state a claim, concluding that

Plaintiffs failed to satisfy the requirements of the Private

Securities Litigation Reform Act (PSLRA), 15 U.S.C. § 78u–

4. We agree and affirm.

I

A. Factual Background2

1. William Erbey and Ocwen Financial

AAMC is one of several independent, but affiliated,

companies founded by William Erbey. The first company,

Ocwen Financial, was created in 1988 and became the

country’s largest purchaser of non-performing mortgage loans

in the 1990s. Companies earn profit from non-performing

mortgages by either efficiently foreclosing on the underlying

(1999). The earliest accounts of Newton’s comment vary

slightly. See Joseph Spence, Anecdotes, Observations, and

Characters 368 (Samuel Singer, ed., 1820).

is taken from the operative complaint and accepted as true.

Krieger v. Bank of Am., N.A., 890 F.3d 429, 434 (3d Cir. 2018).

properties or by bringing the loans to current status. Once

current, the mortgages can either provide a reliable stream of

income or be resold at a premium. Ocwen came to specialize

in the servicing of non-performing loans. Mortgage servicing

is essentially a specialized form of debt collection, but in the

context of non-performing mortgages it is a notoriously

difficult and labor-intensive task. Ocwen gradually

transitioned from primarily servicing its own loans to acquiring

mortgage servicing rights from others. Large mortgage holders

sometimes contract with third parties for loan servicing,

typically paying the servicer a fee based on the unpaid principal

balance of the serviced properties. Business was thin for

Ocwen during the housing boom of the late 1990s and early

2000s because rising property values limited the number of

non-performing mortgages. The large banks, which owned a

majority of U.S. mortgages, were generally able to manage

their own (comparatively few) non-performing loans.

The 2008 housing crisis changed this picture. As droves

of borrowers fell behind on their mortgages, the largest

mortgage holders found themsеlves ill-equipped to service the

ballooning number of delinquent, non-performing loans. This

led to widespread corner-cutting—e.g., robo-signing of

foreclosure documents, fraudulent affidavits, and other abusive

servicing practices—which culminated in the 2012 National

Mortgage Settlement. Under this agreement, the nation’s five

largest mortgage holders, all banks, agreed to provide more

than $50 billion worth of relief to mistreated homeowners.

What was the National Mortgage Settlement?, Consumer Fin.

Prot. Bureau (updated May 10, 2018), perma.cc/CA8Z-E8HC.

In this environment, Ocwen’s experience in servicing

non-performing mortgages proved exceptionally

advantageous—and profitable. As banks sought to avoid the

financial hazards and regulatory scrutiny of servicing non-

performing and sub-prime loans, Ocwen was there to buy up

staggering quantities of mortgage servicing rights. From 2009

to 2013, Ocwen’s servicing portfolio grew from approximately

350,000 properties to more than 2.8 million. Consent Order

Pursuant to New York Banking Law § 44 at 2, In the Matter of

Ocwen Fin. Corp., N.Y. Dep’t Fin. Servs. (Dec. 22, 2014),

perma.cc/26XF-VMM2 (hereinafter the 2014 DFS Consent

Order). The aggregate unpaid principal balance of the

properties Ocwen serviced correspondingly grew from $50

billion to more than $464 billion. Id. By the end of 2013,

Ocwen had become the fourth largest mortgage servicer in the

U.S., and the largest servicer of sub-prime loans. Id. аt 1. In

addition to efficiently servicing and foreclosing on distressed

properties, Ocwen also led the industry with programs

designed to help underwater borrowers stay in their homes. See

Patricia A. McCoy, Barriers to Foreclosure Prevention During

the Financial Crisis, 55 Ariz. L. Rev. 723, 763–64 (2013).

Ocwen’s willingness to expand its role in the mortgage

industry made it attractive to investors looking for

opportunities to rе-enter the market following the 2008 crisis.

Ocwen’s growth and success did not pass without

notice, however. When Ocwen sought to acquire yet another

large portfolio of mortgage servicing rights in 2011, the New

York Department of Financial Services (DFS) raised concerns

about Ocwen’s growth and scalability. As a condition of DFS

approval for the acquisition, Ocwen agreed to abide by a

detailed set of servicing and staffing standards. Agreement on

Mortgage Servicing Practices, N.Y. Dep’t Fin. Servs. (Sep. 1,

2011), perma.cc/M6JW-XEET (hereinafter the 2011 DFS

Agreement). The following year, DFS conducted “a targeted

examination” of Ocwen, which “identified gaps in the

servicing records of certain loans that . . . indicate[d] non-

compliance” with the 2011 agreement. Consent Order Pursuant

to New York Banking Law § 44 at 2–3, In the Matter of Ocwen

Loan Serv., LLC, N.Y. Dep’t Fin. Servs. (Dec. 5, 2012),

perma.cc/5FA8-7SCG (hereinafter the 2012 DFS Consent

Order). As a result, DFS and Ocwen entered into the 2012

consent order, which required Ocwen to install an independent,

on-site monitor to ensure compliance with the 2011 agreement.

Id. at 4. These regulatory actions did not appear to hinder

Ocwen’s financial health, however, as the company’s stock

nearly doubled in the six months following the 2012 order.

2. The Ocwen Spin-offs

Also in December 2012—and directly relevant to this

case—Ocwen completed the spin-off of several independent

companies related to its core mortgage servicing business.

Those companies were Altisource Portfolio Solutions (ASPS),

Altisource Residential Corporation ‍‌‌​​‌​‌‌​​​​‌​‌‌​‌​‌‌‌​​​‌‌‌‌‌‌‌​‌‌​​​​​​​‌‌​​​‌‍(RESI), and the appellee,

Altisource Asset Management Corporation (AAMC).3 As

explained and depicted below, each of these spin-offs—in

conjunction with Ocwen—would work together to profit from

various opportunities within the broader real estate market.

Organizational Chart as of December 31, 2012

directly. ASPS was spun-off from Ocwen in 2009, and in 2012

AAMC and RESI were both spun-off from ASPS.

Image in original document— organizational chart

RESI was created to capitalize on the nationwide

decline in home ownership and the consequent increase in

demand for rental properties. RESI would acquire non-

performing loans, with Ocwen providing the loan servicing. If

the mortgage could be brought current, RESI would sell the

loan for a profit. If not, RESI would foreclose on the home,

take title, and maintain it as a rental property, with property

management services provided by ASPS. This strategy for

converting non-performing loans into rental properties—if

performed efficiently—offered significant financial savings

over the conventional approach of purchasing such properties

at foreclosure auctions. RESI had no employees, and received

asset management and corporate governance services from

AAMC, which itself had only seven employees. RESI—

AAMC’s only client—paid AAMC a management fee based

on RESI’s available assets. Overall, the Ocwen-affiliated

companies were highly interrelated and shared a significant

number of corporate officers. For each company, William

Erbey was the largest individual shareholder and served as

Chairman of the Board.

At first, it appeared as if Erbey and his passel of

affiliated companies could do no wrong, and the stock price of

each company enjoyed a meteoric rise. AAMC, in particular,

began 2013 trading at around $75 per share, but by January

2014 had risen as high as $1,196 per share. Only one year later,

however, AAMC had fallen to $160 a share. Each of the other

Ocwen companies suffered a similаr fate. The claims period in

this case—April 19, 2013 through January 12, 2015—includes

the bulk of this precipitous rise and fall, which resulted, at least

in part, from the persistent regulatory actions taken against

Ocwen during the same time period.

3. Regulatory Pressure

By December 2013, Ocwen was the largest non-bank

mortgage servicer in the U.S. On December 19, 2013, Ocwen

entered into a consent order with the Consumer Financial

Protection Bureau (CFPB) and authorities in 49 states and the

District of Columbia. Consent Judgment, Consumer Fin. Prot.

Bureau v. Ocwen Fin. Corp., No. 13-cv-2025 (D.D.C. Dec. 19,

2013), perma.cc/5KZP-MW6R (hereinafter the 2013 CFPB

Consent Order). A CFPB investigation of Ocwen had

uncovered systemic consumer protection violations, largely

attributed to Ocwen’s breakneck acquisition of mortgage

servicing rights in the preceding years. Pursuant to the 2013

CFPB consent order, Ocwen agreed to refund over $125

million to borrowers who had been wrongfully foreclosed upon

and to provide $2 billion in principal reduction to underwater

homeowners. Id. at 9–10. Ocwen also agreed to abide by the

standards outlined in the National Mortgagе Settlement, id. at

9, becoming the first non-bank to do so.

Throughout 2014, Ocwen and its affiliates also attracted

more scrutiny from DFS and other government actors. In

February, DFS halted a proposed $2.7 billion sale of mortgage

servicing rights to Ocwen from Wells Fargo. Second Amended

Complaint (SAC) ¶ 164. DFS also sent a public letter to Ocwen

voicing its concern with “potential conflicts of interest”

between the Ocwen-related companies. Letter from Benjamin

M. Lawsky, Superintendent, N.Y. Dept. of Fin. Servs., to

Timothy Hayes, General Counsel, Ocwen Fin. Corp. (Feb. 26,

2014), perma.cc/5C52-ZPJ9 (hereinafter the 2014 DFS Letter).

And later in the year, the Department of Housing and Urban

Development (HUD) shut RESI out of a government-

sponsored auction of distressed properties. SAC ¶ 166.

In December 2014, Ocwen entered into yet another

consent order with DFS, precipitated by the findings of the

compliance monitor installed under the 2012 consent order.

2014 DFS Consent Order at 2. The monitor identified several

significant servicing violations by Ocwеn, including (1) failing

to confirm that it had the right to foreclose before initiating

foreclosure proceedings, (2) failing to ensure that its

representations during foreclosure proceedings were correct,

(3) pursuing foreclosure while loan modification applications

were pending, and (4) failing to ensure that no foreclosure

actions were pursued against active duty servicemembers. Id.

at 5–6. As had the CFPB, the DFS compliance monitor traced

many of these problems to widespread technological

deficiencies in Ocwen’s servicing platform. As Ocwen

acquired companies and loan portfolios, it also inherited the

myriad proprietary computer systems used to service those

loans. Id. at 6–7. Ocwen’s efforts to combine these legacy

systems had resulted in a number of incompatibilities that

produced incorrect or outdated loan information. Id. The

monitor also identified several conflicts of interest аmong the

Ocwen-affiliated companies, specifically finding that Erbey

had not recused himself from several transactions between

Ocwen and ASPS, resulting in higher costs for Ocwen. Id. at

9. Pursuant to the 2014 DFS consent order, Ocwen agreed to

pay $150 million in relief to New York homeowners, and

Erbey agreed to resign his positions at Ocwen, ASPS, RESI,

and AAMC. Id. at 10, 17–18.

None of the above-mentioned regulatory actions were

brought against AAMC, nor did any action identify improper

conduct by Erbey relative to his role at AAMC.

B. Procedural History

The initial complaint in this class action was filed on

January 16, 2015 by City of Cambridge Retirement System.

After being appointed as lead plaintiff, Denver Employees

Retirement Plan filed a significantly revised amended

complaint, which it captioned its “Consolidated Complaint.”4

AAMC filed a motion to dismiss the complaint under Federal

Rule of Civil Procedure 12(b)(6), which the District Court

granted. Roughly three weeks later, Plaintiffs sought leave to

reopen the case and further amend the complaint, attaching a

proposed second amended complaint to its motion. After

considering the proposed complaint, the District Court denied

leave to amend as futile. Plaintiffs then filed this timely appeal.

II

The District Court had jurisdiction under 28 U.S.C. §

1331 and 15 U.S.C. § 78aa. We have jurisdiction under 28

U.S.C. § 1291. Generally, a district court’s denial of leave to

amend is reviewed for abuse of discretion. United States ex rel.

Customs Fraud Investigations, LLC v. Victaulic Co., 839 F.3d

242, 248–49 (3d Cir. 2016). Leave to amend is properly denied

if amendment would be futile, i.e., if the proposed complaint

should not have counted the “Consolidated Complaint” as an

amended complaint. This contention is both wrong and

irrelevant. There were not—as is ‍‌‌​​‌​‌‌​​​​‌​‌‌​‌​‌‌‌​​​‌‌‌‌‌‌‌​‌‌​​​​​​​‌‌​​​‌‍frequently the сase—multiple

complaints in need of consolidation, so the only purpose of the

revised complaint was to make substantive amendments. In

any event, because the District Court dismissed due to futility,

the number of prior opportunities Plaintiffs had to amend is

immaterial. See In re Adams Golf, Inc. Sec. Litig., 381 F.3d

267, 280 & n.12 (3d Cir. 2004) (affirming denial of leave to

amend because proposed second amended complaint was

futile); United States ex rel. Customs Fraud Investigations,

LLC v. Victaulic Co., 839 F.3d 242, 252 (3d Cir. 2016)

(suggesting that dеnial of leave to amend the initial complaint

would have been justified if the proposed amendment would

have been futile).

could not “withstand a renewed motion to dismiss.” Jablonski

v. Pan Am. World Airways, Inc., 863 F.2d 289, 292 (3d Cir.

1988). “In assessing ‘futility,’ the district court applies the

same standard of legal sufficiency as applies under Rule

12(b)(6).” In re Burlington Coat Factory Sec. Litig., 114 F.3d

1410, 1434 (3d Cir. 1997). And as to this legal determination,

our review is plenary. Morrow v. Balaski, 719 F.3d 160, 165

(3d Cir. 2013).

In determining whether Plaintiffs’ proposed second

amended complaint states a claim under Rule 12(b)(6), we

accept all well-pleaded allegations as true and draw all

reasonable inferences in favor of the plaintiff. Id. However,

“we disregard threadbare recitals of the elements of a cause of

action, legal conclusions, and conclusory statements.” James

v. City of Wilkes-Barre, 700 F.3d 675, 681 (3d Cir. 2012).

III

A. The Elements of a Rule 10b–5 Claim

The proposed complaint charges AAMC with securities

fraud in violаtion of § 10(b) of the Securities Exchange Act of

1934, 48 Stat. 881, 15 U.S.C. § 78j, and Securities and

Exchange Commission (SEC) Rule 10b–5, 17 C.F.R. §

240.10b–5.5 The 1934 Act prohibits the use of “any

manipulative or deceptive device” in connection with “the

purchase or sale of any security registered on a national

securities exchange.” 15 U.S.C. § 78j(b). More specifically,

Rule 10b–5 makes it unlawful for any person—in connection

with the sale of any security—“[t]o make any untrue statement

AAMC violated § 20(a) of the Securities Exchange Act of

1934. They do not discuss this allegation on appeal, and we do

not consider it in reaching our conclusion.

of a material fact or to omit to state a material fact necessary in

order to make the statements made, in the light of the

circumstances under which they were made, not misleading.”

17 C.F.R. § 240.10b–5(b). To state a claim under Rule 10b–5,

a plaintiff must allege:

(1) a material misrepresentation (or omission);

(2) scienter, i.e., a wrongful state of mind;

(3) a connection with the purchase or sale of a security;

(4) reliance;

(5) economic loss; and

(6) loss causation . . . .

Dura Pharm., Inc. v. Broudo, 544 U.S. 336, 341–42 (2005)

(internal quotation marks, citations, and emphasis omitted). In

this case—and as is typical—the principal contentions relate to

only three elements: a material misrepresentation (or

omission), scienter, and loss causation. See Cal. Pub. Emps.

Ret. Sys. v. Chubb Corp., 394 F.3d 126, 143 (3d Cir. 2004).

In addition to Rule 12(b)(6), pleadings in Rule 10b–5

actions must also satisfy the particularity requirements of both

Rule 9(b) and the Private Securities Litigation Reform Act

(PSLRA), 15 U.S.C. § 78u–4. Id. Rule 9(b) provides that any

fraud allegation “must state with particularity the

circumstances constituting fraud or mistake.” Fed. R. Civ. P.

9(b). The PSLRA prescribes yet greater particularity relative to

the elements of material misrepresentation and scienter. With

respect to material misrepresentation, the PSLRA requires that

a complaint “specify each statement alleged to have been

misleading, the reason or reasons why the statement is

misleading, and, if an allegation . . . is made on information

and belief, . . . all facts on which that belief is formed.” 15

U.S.C. § 78u–4(b)(1). With respect to scienter, complaints

must “state with particularity facts giving rise to a strong

inference that the defendant acted with thе required state of

mind.” Id. § 78u–4(b)(2)(A).6

Far from mere technicalities, enforcement of such

pleading requirements helps avoid the “abusive” practice of

plaintiffs with “largely groundless claim[s] . . . simply tak[ing]

up the time of a number of other people, with the right to do so

representing an in terrorem increment of the settlement value.”

Dura, 544 U.S. at 347 (first quoting H.R. Rep. No. 104–369,

at 31 (1995) (Conf. Rep.); then quoting Blue Chip Stamps v.

Manor Drug Stores, 421 U.S. 723, 741 (1975)). To that end,

the PSLRA seeks “to сurb frivolous, lawyer-driven litigation,

while preserving investors’ ability to recover on meritorious

claims.” Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S.

308, 322 (2007). Allowing claims only in cases of true fraud

avoids converting private securities actions into “a partial

downside insurance policy” against the vicissitudes of the

market. Dura, 544 U.S. at 347–48.

B. Plaintiffs’ Claims

Plaintiffs base their fraud claims on two principal

classes of statements made by AAMC. First, Plaintiffs argue

that AAMC misrepresented the benefits attributable to its

relationship with Ocwen. For example, in its 2012 Annual

Report filed with the SEC, AAMC stated:

alone, remand would be appropriate if we were to determine

that the complaint suffered only from a lack оf particularity.

Burlington Coat Factory, 114 F.3d at 1435. However, because

we conclude that the complaint “would not survive a Rule

12(b)(6) motion even if pled with more particularity,” no

remand is necessary. Id.

[W]e believe that [RESI’s] access to Ocwen’s

servicing expertise helps it to maximize the value

of its loan portfolios and provides it with a

competitive advantage over other companies

with a similar focus.

J.A. 275. Plaintiffs allege that this statement was “materially

false and misleading because [it] portrayed Ocwen as a benefit

and a ‘competitive advantage’ to RESI, when Ocwen was

neither,” SAC ¶ 138, because of its outdated servicing platform

and regulatory violations.

The second category of alleged misrepresentations

concerns AAMC’s stated policy of requiring its officers—

Erbey in particular—to recuse themselves from any

transactions involving оther Ocwen-affiliated companies. In its

2013 Annual Report, AAMC stated:

Each of our executive officers is also an

executive officer of [RESI] and has interests in

our relationship with [RESI] that may be

different than the interests of our

stockholders. . . . We follow policies, procedures

and practices to avoid potential conflicts with

respect to our dealings with [ASPS], Ocwen and

[RESI], including our Chairman [Erbey]

recusing himself from negotiations regarding,

and approvals of, transactions with these

entities . . . .

J.A. 324. Plaintiffs allege that this disclosure was “false and

misleading because it omits to disclose ‍‌‌​​‌​‌‌​​​​‌​‌‌​‌​‌‌‌​​​‌‌‌‌‌‌‌​‌‌​​​​​​​‌‌​​​‌‍that the Related-Party

Transaction Policy was widely disregarded by Defendant

Erbey and others.” SAC ¶ 144.

The District Court concluded that Plaintiffs’ allegations

failed to plausibly allege either a material falsе statement or

loss causation. It did not reach the question of scienter, but on

appeal AAMC has renewed its argument that the complaint

should fail on that basis as well. The following sections will

analyze whether either class of alleged misrepresentations by

AAMC is sufficient tо survive a challenge under Rule 12(b)(6)

and the PSLRA.7 With regard to the statements concerning

AAMC’s relationship with Ocwen, we conclude that Plaintiffs

have not plausibly alleged that the statements were false, and,

therefore, we need not determine whether Plaintiffs

sufficiently pled scienter or loss causation. With regard to

AAMC’s recusal policy, we conclude that Plaintiffs’ fаilure to

identify a single AAMC transaction in which Erbey—or some

other officer—improperly participated renders its allegations

too speculative to meet the PSLRA’s strict requirements.

1. Falsity

The complaint contains dozens of statements from

various Ocwen-affiliated companies—not only, or even

primarily, AAMC—that Plaintiffs characterize as material

misrepresentations. On the question of falsity, then, the first

issue to address is the legal significance of statements made by

companies other than AAMC. Rule 10b–5 makes it unlawful

for any person to “make any untrue statement of a material

fact,” 17 C.F.R. § 240.10b–5(b), and, with regard to this rule,

“the maker of a statement is the person or entity with ultimate

authority over the statement,” Janus Capital Grp., Inc. v. First

Derivative Traders, 564 U.S. 135, 142 (2011). Therefore, in

considering whether AAMC made any material

heightened pleading standards will also satisfy Rule 9(b)’s

requirements.

misrepresentations, we will consider only the statements of

AAMC (and not RESI, Ocwen, or other affiliated companies).

i. Statements Concerning AAMC’s Relationship with

Ocwen

As detailed above, Ocwen underwent significant

regulatory scrutiny before, during, and after the claims period,

and multiple regulatory bodies sanctioned it for improper

servicing practices. In various filings and public statements,

AAMC described its relationship with RESI and, in turn,

RESI’s relationship with Ocwen. Plaintiffs allege that (1)

AAMC knew that Ocwen’s servicing platform was severely

flawed and therefore a detriment to AAMC, and (2) AAMC’s

failure to disclose this information about Oсwen constituted a

material omission.

AAMC provided a detailed explanation of its

relationship with Ocwen in its 2013 Annual Report under the

heading “Risks Related to Our Management and Our

Relationships with [ASPS], Ocwen, and [RESI]”:

[RESI] is contractually obligated to service the

residential mortgage loans that it acquires.

[RESI] does not have any employees, servicing

platform, licenses or technical resources

necessary to service its acquired loans.

Consequently, [RESI] has engaged Ocwen to

service the non-performing and sub-

performing . . . loans it acquires. If for any

reason Ocwen is unable to service these loans at

the level and/or the cost that [RESI]

anticipates, . . . an alternate servicer may not be

readily available on favorable terms, or at all,

which could have a material adverse effect on

[RESI].

J.A. 323, 324. Thus, the annual report explained that RESI

depended on Ocwen for loan servicing and would be at risk if

it needed to find a different servicer. The same report also made

clear that, because RESI was AAMC’s sole source of revenue,

any risk to RESI applied in equal measure to AAMC. J.A. 309–

10.

Plaintiffs argue that, in order to make this report (and

others likе it) not misleading, AAMC was obligated to disclose

its awareness of problems with Ocwen’s servicing platform.

But in the context in which these statements were made, there

was nothing false or misleading about AAMC’s assertions. The

above-quoted report does not imply anything about the quality

of Ocwen’s loan servicing, only its capacity (high) and its cost

(low). Plaintiffs have not alleged that AAMC had any reason

to believe that Ocwen, whatever its flaws, would be unable to

service all of the loans RESI sent its way. Nor is there any

allegation that Ocwen ever did fail to meet its servicing

obligation to RESI. Given that context, there was nothing

misleading about AAMC’s disclosed reliance on Ocwen. By

contrast, suppose AAMC knew at the time of this report that

Ocwen would soon be unable to take on any additional

mortgage servicing rights obligations. In that case, AAMC’s

statement would be misleading because what it identified as a

possible risk, was, in truth, known to be imminent.8

In effect, Plaintiffs suggest that AAMC’s reference to

Ocwen carried some form of implied warranty. Plaintiffs

exhaustively catalogue Ocwen’s regulatory violations, but cite

no authority to support the conclusion that AAMC was

obligated to disclose the flaws of a separate entity in its own

filings. Even assuming that such an obligation could arise in

some cases, it would make no sense to impose such a

requirement where, as here, the allegedly “concealed”

information—Ocwen’s regulatory failures—was not only

well-known, but typical of most mortgage servicers at the time.

McCoy, supra, 55 Ariz. L. Rev. at 748 (noting a 2011 Treasury

Department investigation, which concluded that each of the ten

largest servicers in the Home Affordable Modification

Program was deficient); Vincent Di Lorenzo, Corporate

Wrongdoing: Interactions of Legal Mandates and Corporate

Culture, 36 Rev. Banking & Fin. L. 207, 226 (2016)

praising Ocwen, e.g., “We intend ‍‌‌​​‌​‌‌​​​​‌​‌‌​‌​‌‌‌​​​‌‌‌‌‌‌‌​‌‌​​​​​​​‌‌​​​‌‍to capitalize on the servicing

capabilities of Ocwen, which we view as superior relative to

other servicers in terms of cost, management experience,

technology infrastructure and platform scalability.” SAC ¶

136. Such statements are not false because they clearly convey

a subjective opinion. Moreover, we have consistently held that

such “vague and general statements of optimism” are non-

actionable precisely because they are not material, i.e., a

reasonable investor would not base decisions on such

statements. See In re Advanta Corp. Sec. Litig., 180 F.3d 525,

538–39 (3d Cir. 1999), abrogated on other grounds as

recognized by Inst. Inv’rs Grp. v. Avaya, Inc., 564 F.3d 242,

276 (3d Cir. 2009).

(describing mortgage servicing as a “distinct industry-wide

example of improper conduct,” and discussing a 2015

Comptroller of the Currency investigation, which found

repeated noncompliance with servicing standards by several

parties to the 2012 National Mortgage Settlement); see

generally Matthew Goldstein, Rachel Adams, & Ben Protess,

How Housing’s New Players Spiraled Into Banks’ Old

Mistakes, N.Y. Times, June 26, 2016, goo.gl/GoYTqv.

Under Rule 10b–5, the misleading nature of a statement

is evaluated “in the light of the circumstances under which” it

is made. 17 C.F.R. § 240.10b–5(b). As was clear under these

circumstances, AAMC’s statements about Ocwen were

relevant only insofar as RESI—and, by extension, AAMC—

depended on Ocwen to service the mortgages it acquired.

AAMC had no reason to believe that Ocwen would be unable

to fill this role, so its statements to this effect were not

misleading.

ii. Statements Concerning AAMC’s Recusal Policy

AAMC claimed in various disclosures that it had

“policies, procedures and practices” to avoid potential conflicts

with respect to the other Ocwen-affiliated companies. J.A. 324.

In particular, these policies required Erbey to “recus[e] himself

from negotiations regarding, and approvals of, transactions

with” those companies. Id. Plaintiffs allege that these

statements were false and misleading because, in reality, Erbey

had not recused himself from decisions concerning several

related-party transactions. To support this allegation, the

complaint primarily relies on a 2015 cease-and-desist order

issued by the SEC, which concluded that Erbey had failed to

recuse himself from certain transactions between Ocwen and

another affiliated company, HLSS. According to Plaintiffs, this

finding “raises a strong inference that [the defendants] acted in

a similar manner with respect to AAMC.” SAC ¶ 145; see id.

at ¶ 107 (quoting In the Matter of Home Loan Serv. Sols., Ltd.,

SEC Release No. 3713, 2015 WL 5782427, at *1–2 (Oct. 5,

2015)).

By their own admission, Plaintiffs’ allegation regarding

AAMC’s recusal policy relies on an inference from Erbey’s

conduct with regard to two separate companies. Even

accepting that the stringent pleading rеquirements applicable

to Rule 10b–5 actions should be “relaxed somewhat where the

factual information is peculiarly within the defendant’s

knowledge or control,” Burlington Coat Factory, 114 F.3d at

1418, we cannot credit factual allegations, such as this, which

do not rise “above the speculative level,” Bell Atl. Corp. v.

Twombly, 550 U.S. 544, 555 (2007). By not identifying a single

AAMC transaction in which Erbey improperly participated,

the complaint attempts to establish falsity through the very sort

of “speculative fraud by hindsight that the [PSLRA] was

intended to eliminate.” In re Rockefeller Ctr. Properties, Inc.

Sec. Litig., 311 F.3d 198, 225 (3d Cir. 2002).

*

Plaintiffs allege that AAMC misrepresented both the

benefits of its relationship with Ocwen and its adherence to a

recusal policy designed to protect agаinst conflicts of interest.

However, Plaintiffs have failed to sufficiently plead falsity as

to either category. The statements concerning AAMC’s

relationship with Ocwen were not misleading in the context in

which they were made because AAMC’s reliance on Ocwen

only extended to its ability to service the loans acquired by

AAMC. Likewise, the complaint does not plausibly allege that

AAMC’s statements about its recusal policy were false or

misleading. Instead, it simply speculates that Erbey must have

violated the AAMC recusal policy because he is suspected to

have done so with other companies. Neither allegation satisfies

the PSLRA’s strict standards for stating a claim.

2. Scienter and Loss Causation

Even if Plaintiffs had sufficiently alleged that AAMC

made false or misleading statements, this alone would not be

enough to survive a motion to dismiss. Plaintiffs must also

plead facts sufficient to create a “strong inference” that AAMC

intended to defraud shareholders (scienter), 15 U.S.C. § 78u–

4(b)(2)(A), and adequately allege that, when the truth was

revealed about those fraudulent statements, Plaintiffs suffered

an economic harm as a result (loss causation), Dura, 544 U.S.

at 341-42. Both factors are predicated upon a sufficient

pleading of false or misleading statements. Because we hold

that Plaintiffs failed to satisfy this first requirement, we decline

to go so far as to postulate whether AAMC may have intended

to defraud shareholders with non-fraudulent statements. Nor

do we speculate whether statements made—that do not correct

or contradict misleading statements by AMMC—could

reasonably have caused economic harm to Plaintiffs. Instead,

we conclude our analysis at our finding of no falsity and hold

that Plaintiffs have not stated a claim upon which relief can be

granted.

IV

The economic harm suffered by AAMC’s investors is

certainly regrеttable, but Plaintiffs fail to plausibly allege that

this harm arose from fraud. When a stock experiences the rapid

rise and fall that occurred here, it will not usually prove

difficult to mine from the economic wreckage a few

discrepancies in the now-deflated company’s records. See H.R.

Rep. No. 104–369, at 31 (1995) (Conf. Rep.). Hindsight,

however, is not a cause of action. In passing the PSLRA,

Congress concluded that the very stability of our capital

markets depends on forestalling meritless suits while

preserving for “defrauded investors” ‍‌‌​​‌​‌‌​​​​‌​‌‌​‌​‌‌‌​​​‌‌‌‌‌‌‌​‌‌​​​​​​​‌‌​​​‌‍the “indispensable tool”

of private litigation. Id. Because Plaintiffs’ complaint falls on

the wrong side of this carefully-struck balance, we will affirm

the decision of the District Court.

Notes

1
1 Edward Chancellor, Devil Take the Hindmost 69
2
2 This factual background, unless otherwise indicated,
3
3 AAMC and RESI were not spun-off from Ocwen
4
4 Plaintiffs continue to contend that the District Court
5
5 Plaintiffs’ proposed complaint also alleges that
6
6 Because the District Court ruled on futility grounds
7
7 In general, a complaint that satisfies the PSLRA’s
8
8 The complaint highlights other AAMC statements

Case Details

Case Name: City of Cambridge Retirement v. Altisource Asset Management Co
Court Name: Court of Appeals for the Third Circuit
Date Published: Nov 14, 2018
Citations: 908 F.3d 872; 17-2471
Docket Number: 17-2471
Court Abbreviation: 3rd Cir.
AI-generated responses must be verified
and are not legal advice.
Log In